RACK1 and ovarian carcinoma: Herein, we confirmed that RACK1 is MARylated in OVCAR3 ovarian cancer cells using immunoprecipitation of endogenous RACK1, followed by immunoblotting with an antibody-like MAR detection reagent (Gibson et al., 2017) (Fig. 1 B; and Fig. S1, A and B).